Gold nanoparticles (AuNPs) were successfully used to deliver miR-326 in HCC models, suppressing the 3-phosphoinositide-dependent protein kinase 1 (PDK1)/Akt/c-Myc axis and reducing EMT and tumor growth in vivo [96]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.